VRTX

Vertex Says Pediatric CASGEVY Data Show Consistent Benefits In Rare Blood Disorders

06/11 12:20 pm

Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?

06/08 02:34 pm

CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential

06/03 12:30 pm

CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?

05/31 12:11 pm

Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?

05/25 08:35 pm

1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?

05/11 04:15 pm

Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight

05/11 01:00 pm

Is This Millionaire-Maker Biotech Stock a Buy Right Now?

05/06 03:30 am

Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying?

05/02 03:30 am

Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering

04/30 06:10 am

What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.

04/30 05:10 am

Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?

04/30 03:10 am

IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight

04/29 01:00 pm

3 Healthcare Stocks With the Most Durable Competitive Moats

04/23 04:05 am

CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?

04/21 01:30 pm

Is Vertex Pharmaceuticals' Empire in Trouble?

04/16 03:26 pm

Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells

04/10 09:55 am

Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications

04/07 01:44 pm

Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight

04/06 01:00 pm

Where Will Vertex Pharmaceuticals Be in 1 Year?

03/25 04:02 pm

Anti-Aging Protein Research Takes a Step Forward with Cell Cloning

03/24 11:05 am

CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?

03/23 01:30 pm

My Top 3 Drug Stocks for March 2026

03/20 06:30 am

Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals

03/19 02:30 pm

UNCF NEW ENGLAND Raises Record-Breaking $800,000 for HBCUs and Student Success

03/19 07:00 am

Is Vertex Pharmaceuticals Heading to $600?

03/15 09:15 pm

Oil Crashes 10%, Stocks Rebound On Trump End-Of-War Signals: What's Moving Markets Tuesday?

03/10 01:03 pm

Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps

03/10 09:24 am

2 Biotech Giants to Buy in 2026

03/05 09:15 am

Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of

03/04 02:23 pm

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

03/03 09:00 am

2 Top Healthcare Stocks to Buy in February

02/26 03:15 pm

Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline

02/26 02:30 pm

The Ultimate Biotech Stock to Buy With $500 Right Now

02/24 04:30 am

Could Vertex Stock Help Turn $100,000 Into $1 Million by 2036?

02/22 07:30 pm

CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows

02/20 11:22 am

The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026

02/13 04:10 pm

Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday?

02/13 02:48 pm

CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens

02/13 02:45 pm

1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell

02/10 02:15 pm

Should You Buy Vertex Before Feb. 12?

02/10 10:35 am

Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

02/03 02:56 am

Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica

01/27 02:43 pm

Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets

01/23 01:56 pm

Stock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700%

01/15 06:27 pm

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

01/14 12:15 pm

Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026

01/09 10:30 am

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

01/08 08:00 am

My 10 Top Stocks to Buy to Start the New Year Off Right

01/05 09:15 pm

Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize

01/02 02:29 pm